Palvella Therapeutics Inc <PVLA.OQ> expected to post a loss of 74 cents a share - Earnings Preview
Palvella Therapeutics Inc PVLA.OQ PVLA.O is expected to report resultson August 14 for the period ending June 30 2025
LSEG's mean analyst estimate for Palvella Therapeutics Inc is for a loss of 74 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Palvella Therapeutics Inc is $50.00, about 16.6% above its last closing price of $41.71
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -1.30 | -1.21 | -0.74 | Beat | 38.9 |
Dec. 31 2025 | -0.66 | -0.64 | -2.72 | Missed | -321.7 |
| |||||
| |||||
-3.70 | | ||||
Sep. 30 2023 | -8.80 | -8.80 | 3.20 | Beat | 136.4 |
Jun. 30 2023 | -12.80 | -12.80 | 4.00 | Beat | 131.3 |
This summary was machine generated August 12 at 12:57 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
China July Money Supply Commentary: M2 Growth Rises More Than Expected
The relatively large increase in M2 mainly stems from two factors: first, the impact of a low base formed by the relatively low growth rate of M2 in the same period last year; second, the resolution of debts has promoted the improvement of corporate capital flows.
Applied Materials Q3 Earnings: AI Demand Soars, but Cautious Guidance Triggers After-Hours Selloff
TradingKey - Applied Materials, Inc. (NASDAQ: AMAT) announced its Q3 FY2025 earnings on August 14, 2025, after market close, reporting strong revenue fueled by AI-related semiconductor demand, which beat expectations. However, cautious Q4 guidance, including EPS below analyst estimates.jpg)
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing.
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,
